FDA product code · Physical medicine
Wheelchair, Stair Climbing
5 FDA decisions since 1991. 510(k) reviews decided 2021–2025 took a median of 82 days (half between 81 and 84). 3 recalls name this code, 0 of them Class I. The most-cited predicate is P020033/
A device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position. The device is intended to climb stairs. FDA interprets “mobility to persons restricted to a sitting position” to mean the device type is intended to provide mobility to individuals who have mobility impairments and require an assistive device for mobility.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of IMK at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · IMK
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · IMK
Too few IMK 510(k)s in any year since 2007 to give a median.
Recalls per year · IMK
1in 2010
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · IMK
10in 2025
MAUDE reports naming product code IMK, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 8 |
| 2008 | 0 | — | 0 | 12 |
| 2009 | 0 | — | 0 | 11 |
| 2010 | 0 | — | 1 | 5 |
| 2011 | 0 | — | 0 | 5 |
| 2012 | 0 | — | 0 | 4 |
| 2013 | 0 | — | 0 | 1 |
| 2014 | 0 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 4 |
| 2022 | 0 | — | 0 | 3 |
| 2023 | 0 | — | 0 | 2 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 1 | — | 0 | 10 |
| 2026 | 0 | — | 0 | — |
Planning a device in IMK? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report